Search by Drug Name or NDC
NDC 10135-0314-01 Sennosides 8.6 mg/1 Details
Sennosides 8.6 mg/1
Sennosides is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Marlex Pharmaceuticals Inc. The primary component is SENNOSIDES.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 10135-0314-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 10135-0314 |
|---|---|
| Product ID | 10135-314_0a368d4d-f481-2519-e063-6294a90a2a0f |
| Associated GPIs | 46200060200303 |
| GCN Sequence Number | 019964 |
| GCN Sequence Number Description | sennosides TABLET 8.6 MG ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 00701 |
| HICL Sequence Number | 001289 |
| HICL Sequence Number Description | SENNOSIDES |
| Brand/Generic | Generic |
| Proprietary Name | Sennosides |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sennosides |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8.6 |
| Active Ingredient Units | mg/1 |
| Substance Name | SENNOSIDES |
| Labeler Name | Marlex Pharmaceuticals Inc |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M007 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10135-0314-01 (10135031401)
| NDC Package Code | 10135-314-01 |
|---|---|
| Billing NDC | 10135031401 |
| Package | 1 BOTTLE in 1 CARTON (10135-314-01) / 100 TABLET in 1 BOTTLE |
| Marketing Start Date | 2018-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |